Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer
Clinical trial NCT06591910 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06591910
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-20
- Primary completion
- 2026-09-20
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.